Multiple lines of evidence suggest that LPCAT3 is involved in several diseases, including atherosclerosis, non‐alcoholic steatohepatitis, and carcinoma. The gene discussed is LPCAT3; the disease is metabolic dysfunction-associated steatohepatitis.